Forsta AP Fonden boosted its position in The Allstate Corporation (NYSE:ALL – Free Report) by 31.1% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 117,500 shares of the insurance provider’s stock after purchasing an additional 27,900 shares during the period. Forsta AP Fonden’s holdings in Allstate were worth $23,654,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Arlington Trust Co LLC boosted its position in shares of Allstate by 261.8% during the 2nd quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 89 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Allstate by 315.0% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock worth $33,000 after buying an additional 126 shares in the last quarter. Hilltop National Bank acquired a new stake in shares of Allstate during the 2nd quarter worth approximately $34,000. Meeder Asset Management Inc. grew its position in shares of Allstate by 113.8% during the 1st quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider’s stock worth $39,000 after buying an additional 99 shares during the period. Finally, Chilton Capital Management LLC acquired a new position in shares of Allstate during the 2nd quarter valued at $38,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Price Performance
Shares of NYSE:ALL opened at $209.16 on Thursday. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The stock has a market cap of $54.73 billion, a PE ratio of 9.83, a price-to-earnings-growth ratio of 0.69 and a beta of 0.35. The stock’s fifty day simple moving average is $202.04 and its two-hundred day simple moving average is $201.45. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $215.70.
Analyst Ratings Changes
A number of equities research analysts have commented on the stock. Keefe, Bruyette & Woods raised their price target on shares of Allstate from $246.00 to $250.00 and gave the stock an “outperform” rating in a report on Tuesday. Cantor Fitzgerald raised Allstate to a “hold” rating in a research note on Wednesday, August 13th. JPMorgan Chase & Co. boosted their price objective on Allstate from $254.00 to $260.00 and gave the company an “overweight” rating in a report on Thursday, November 6th. Wall Street Zen cut Allstate from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 8th. Finally, Jefferies Financial Group lifted their price target on shares of Allstate from $254.00 to $255.00 and gave the company a “buy” rating in a research report on Monday, August 11th. Two analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $237.13.
Check Out Our Latest Analysis on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- Trading Halts Explained
- Rare Earth Stocks: The Truce That Isn’t a Truce
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- What is a Special Dividend?
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
